Paper36939655
Anti-vascular endothelial growth factor for proliferative diabetic retinopathy.
Martinez-Zapata MJ and 8 others. Cochrane Database Syst Rev, 2023. Cited by 30 papers, by iCite.
Cite this record
ConductScience Library. Anti-vascular endothelial growth factor for proliferative diabetic retinopathy. Papers, record 36939655. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36939655
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetes Mellitus | Major topic |
| Diabetic Retinopathy | Major topic |
| Aged | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Ranibizumab | |
| Vascular Endothelial Growth Factor A | |
| Vitreous Hemorrhage |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Update of | 25418485 | Anti-vascular endothelial growth factor for proliferative diabetic retinopathy. | https://conductscience.org/library/papers/25418485 |
Source PubMed
References170
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30905643 | Simultaneous Inhibition of Angiopoietin-2 and Vascular Endothelial Growth Factor-A with Faricimab in Diabetic Macular Edema: BOULEVARD Phase 2 Randomized Trial. | Ophthalmology | 2019 | https://conductscience.org/library/papers/30905643 | PubMed |
| 2 | 3802833 | Meta-analysis in clinical trials. | Control Clin Trials | 1986 | https://conductscience.org/library/papers/3802833 | PubMed |
| 3 | 19668420 | Intravitreal bevacizumab as an adjunctive therapy before diabetic vitrectomy. | Clin Ophthalmol | 2008 | https://conductscience.org/library/papers/19668420 | PubMed |
| 4 | 29135802 | PANRETINAL PHOTOCOAGULATION VERSUS RANIBIZUMAB FOR PROLIFERATIVE DIABETIC RETINOPATHY: Comparison of Peripapillary Retinal Nerve Fiber Layer Thickness in a Randomized Clinical Trial. | Retina | 2019 | https://conductscience.org/library/papers/29135802 | PubMed |
| 5 | 2062513 | Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. | Ophthalmology | 1991 | https://conductscience.org/library/papers/2062513 | PubMed |
| 6 | 30834517 | Anti-vascular endothelial growth factor for neovascular age-related macular degeneration. | Cochrane Database Syst Rev | 2019 | https://conductscience.org/library/papers/30834517 | PubMed |
| 7 | 26630313 | INTRAVITREAL CONBERCEPT (KH902) FOR SURGICAL TREATMENT OF SEVERE PROLIFERATIVE DIABETIC RETINOPATHY. | Retina | 2016 | https://conductscience.org/library/papers/26630313 | PubMed |
| 8 | 2866759 | Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. | Arch Ophthalmol | 1985 | https://conductscience.org/library/papers/2866759 | PubMed |
| 9 | 2684072 | Is blood pressure a predictor of the incidence or progression of diabetic retinopathy? | Arch Intern Med | 1989 | https://conductscience.org/library/papers/2684072 | PubMed |
| 10 | 19699531 | Intravitreal bevacizumab for prevention of early postvitrectomy hemorrhage in diabetic patients: a randomized clinical trial. | Ophthalmology | 2009 | https://conductscience.org/library/papers/19699531 | PubMed |
| 11 | 11549592 | Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide. | Am J Pathol | 2001 | https://conductscience.org/library/papers/11549592 | PubMed |
| 12 | 20606024 | Intravitreal triamcinolone and bevacizumab as adjunctive treatments to panretinal photocoagulation in diabetic retinopathy. | Br J Ophthalmol | 2010 | https://conductscience.org/library/papers/20606024 | PubMed |
| 13 | 33631120 | Intravitreal anti-vascular endothelial growth factor versus panretinal LASER photocoagulation for proliferative diabetic retinopathy: a systematic review and meta-analysis. | Can J Ophthalmol | 2021 | https://conductscience.org/library/papers/33631120 | PubMed |
| 14 | 35257962 | Final Outcomes from the Randomized RECOVERY Trial of Aflibercept for Retinal Nonperfusion in Proliferative Diabetic Retinopathy. | Ophthalmol Retina | 2022 | https://conductscience.org/library/papers/35257962 | PubMed |
| 15 | 23370902 | Randomized clinical trial evaluating intravitreal ranibizumab or saline for vitreous hemorrhage from proliferative diabetic retinopathy. | JAMA Ophthalmol | 2013 | https://conductscience.org/library/papers/23370902 | PubMed |
| 16 | 11126403 | Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes. | Diabetologia | 2000 | https://conductscience.org/library/papers/11126403 | PubMed |
| 17 | 27034822 | A Randomized Controlled Trial of Conbercept Pretreatment before Vitrectomy in Proliferative Diabetic Retinopathy. | J Ophthalmol | 2016 | https://conductscience.org/library/papers/27034822 | PubMed |
| 18 | 28492920 | Cost-effectiveness of Intravitreous Ranibizumab Compared With Panretinal Photocoagulation for Proliferative Diabetic Retinopathy: Secondary Analysis From a Diabetic Retinopathy Clinical Research Network Randomized Clinical Trial. | JAMA Ophthalmol | 2017 | https://conductscience.org/library/papers/28492920 | PubMed |
| 19 | 16508426 | Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage. | Retina | 2006 | https://conductscience.org/library/papers/16508426 | PubMed |
| 20 | 13129861 | Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. | Ophthalmology | 2003 | https://conductscience.org/library/papers/13129861 | PubMed |
Cited by24
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42911229 | The role and mechanism of the miR-137 regulatory axis in diabetic retinopathy. | Graefes Arch Clin Exp Ophthalmol | 2026 | https://conductscience.org/library/papers/42911229 | PubMed |
| 42899182 | Comparison of the efficacy and safety of conbercept plus panretinal photocoagulation versus panretinal photocoagulation alone for proliferative diabetic retinopathy: A multicenter, prospective, randomized controlled study. | Adv Ophthalmol Pract Res | 2026 | https://conductscience.org/library/papers/42899182 | PubMed |
| 42808830 | L-Threonic Acid Inhibits Pathological Retinal Neovascularization by Modulation of CCL3-CCR5 Signaling Pathway. | Invest Ophthalmol Vis Sci | 2026 | https://conductscience.org/library/papers/42808830 | PubMed |
| 42226292 | FTO-modulated m6A demethylation and upregulation of KIF11 mRNA promotes retinal microvascular dysfunction in diabetic retinopathy. | J Transl Med | 2026 | https://conductscience.org/library/papers/42226292 | PubMed |
| 41721853 | The CAPA framework: a conceptual model integrating corrective and preventive strategies for retinal ischemia and neovascularization. | Graefes Arch Clin Exp Ophthalmol | 2026 | https://conductscience.org/library/papers/41721853 | PubMed |
| 41601934 | Antibody-based therapeutics and therapeutic development for diabetic retinopathy: targeting VEGF, Ang/Tie, and inflammatory pathways. | Front Endocrinol (Lausanne) | 2025 | https://conductscience.org/library/papers/41601934 | PubMed |
| 41453592 | Elevated Retinal Neovascularization on Widefield Optical Coherence Tomography Angiography Predicts Complications in High-Risk Proliferative Diabetic Retinopathy. | Am J Ophthalmol | 2026 | https://conductscience.org/library/papers/41453592 | PubMed |
| 41190783 | Single-Cell RNA Sequencing of Retina Reveals Nna1 Upregulation in Myopic Diabetic Retinopathy as a Protective Factor Against Diabetic Damage. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41190783 | PubMed |
| 41148385 | Efficacy of intravitreal injection of anti-vascular endothelial growth factor as an adjunctive treatment for proliferative diabetic retinopathy before pars plana vitrectomy: a systematic evaluation and meta-analysis. | Int Ophthalmol | 2025 | https://conductscience.org/library/papers/41148385 | PubMed |
| 41113340 | Integrative Management of High-Risk Proliferative Diabetic Retinopathy: Precision Diagnostics via Ultra-Widefield Imaging and Therapeutic Strategies. | Diabetes Metab Syndr Obes | 2025 | https://conductscience.org/library/papers/41113340 | PubMed |
| 40989161 | Petunidin attenuates lipopolysaccharide-induced retinal microglia inflammatory response in diabetic retinopathy by targeting OGT/NF-κB/LCN2 axis. | Open Med (Wars) | 2025 | https://conductscience.org/library/papers/40989161 | PubMed |
| 40891775 | Sustained Benefit of Short-Term Levodopa Treatment on Inner Retinal Function in Patients With Diabetes. | Transl Vis Sci Technol | 2025 | https://conductscience.org/library/papers/40891775 | PubMed |
| 40688778 | Sodium-glucose cotransporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors on diabetic macular edema and the need for intravitreal injection. | Int J Ophthalmol | 2025 | https://conductscience.org/library/papers/40688778 | PubMed |
| 40534817 | Association between findings in nailfold capillaroscopy and diabetic retinopathy: a systematic review and Meta-analysis. | Int J Ophthalmol | 2025 | https://conductscience.org/library/papers/40534817 | PubMed |
| 40385017 | Predictive value of liver and kidney function and bone metabolism markers for postoperative outcomes in diabetic retinal surgery. | Am J Transl Res | 2025 | https://conductscience.org/library/papers/40385017 | PubMed |
| 40367061 | Targeting long non-coding RNA RP11-502I4.3 inhibits the trend of angiogenesis in diabetic retinopathy. | PLoS One | 2025 | https://conductscience.org/library/papers/40367061 | PubMed |
| 40253339 | Peptides based on the interface of hnRNPA2B1-transthyretin complex repress retinal angiogenesis in diabetic retinopathy. | J Transl Med | 2025 | https://conductscience.org/library/papers/40253339 | PubMed |
| 40164888 | The Role of Non-coding RNAs in Diabetic Retinopathy: Mechanistic Insights and Therapeutic Potential. | Mol Neurobiol | 2025 | https://conductscience.org/library/papers/40164888 | PubMed |
| 39430009 | Vascular endothelial growth factor/connective tissue growth factor and proteomic analysis of aqueous humor after intravitreal conbercept for proliferative diabetes retinopathy. | Int J Ophthalmol | 2024 | https://conductscience.org/library/papers/39430009 | PubMed |
| 39141830 | Advances in Extracellular-Vesicles-Based Diagnostic and Therapeutic Approaches for Ocular Diseases. | ACS Nano | 2024 | https://conductscience.org/library/papers/39141830 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| VEGFA | 7422 | PubTator's text mining | https://conductscience.org/library/genes/7422 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36939655
GET https://conductscience.org/api/papers/v1/36939655/references?page=2